{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:12:03Z","timestamp":1790507523584,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"National Development Agency","doi-asserted-by":"publisher","award":["KTIA_NAP_13-1-2013-0001"],"award-info":[{"award-number":["KTIA_NAP_13-1-2013-0001"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005086","name":"Hungarian Brain Research Program","doi-asserted-by":"publisher","award":["KTIA_13_NAP-A-II\/14"],"award-info":[{"award-number":["KTIA_13_NAP-A-II\/14"]}],"id":[{"id":"10.13039\/501100005086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences and the Hungarian Brain Research Program","doi-asserted-by":"publisher","award":["KTIA_NAP_13-2-2015-0001"],"award-info":[{"award-number":["KTIA_NAP_13-2-2015-0001"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.coph.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T21:00:24Z","timestamp":1469221224000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Psychological side effects of immune therapies: symptoms and pathomechanism"],"prefix":"10.1016","volume":"29","author":[{"given":"David","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Eszlari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Juhasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.06.008_bib0295","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.06.008_bib0300","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity","volume":"500","author":"Dantzer","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2016.06.008_bib0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/mp.2012.2","article-title":"The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)","volume":"18","author":"Raison","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_sbref0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2016.06.008_bib0315","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2165\/00003495-200363110-00001","article-title":"Is there a role for adjuvant high-dose interferon-alpha-2b in the management of melanoma?","volume":"63","author":"Sabel","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.coph.2016.06.008_bib0320","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cytogfr.2014.07.015","article-title":"Success in anti-viral immunotherapy","volume":"25","author":"Lin","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coph.2016.06.008_bib0325","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/CJI.0b013e3181e032e8","article-title":"Immunotherapy for melanoma: current status and perspectives","volume":"33","author":"Alexandrescu","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.coph.2016.06.008_bib0330","doi-asserted-by":"crossref","first-page":"20047","DOI":"10.1074\/jbc.R700004200","article-title":"The interferons: 50 years after their discovery, there is much more to learn","volume":"282","author":"Pestka","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.06.008_bib0335","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/appi.ajp.2013.12121572","article-title":"Psychiatric clearance for patients started on interferon-alpha-based therapies","volume":"170","author":"Lotrich","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0340","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement","volume":"57","author":"Schaefer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.coph.2016.06.008_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2016.02.013","article-title":"Subtypes of depressive symptoms and inflammatory biomarkers: an exploratory study on a sample of HIV-positive patients","author":"Norcini Pala","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2009.02.017","article-title":"Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?","volume":"119","author":"Capuron","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.coph.2016.06.008_bib0355","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00702-016-1506-9","article-title":"Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes","volume":"123","author":"Kovacs","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.coph.2016.06.008_bib0360","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2016.06.008_bib0365","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12253-014-9777-7","article-title":"Psychological changes in melanoma patients during ipilimumab treatment compared to low-dose interferon alpha therapy\u2014a follow-up study of first experiences","volume":"20","author":"Kovacs","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.coph.2016.06.008_bib0370","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JCP.0b013e31825d9982","article-title":"Symptomatic treatment of interferon-alpha-induced depression in hepatitis C: a systematic review","volume":"32","author":"Baraldi","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.coph.2016.06.008_bib0375","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/annonc\/mdn001","article-title":"Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis","volume":"19","author":"Garbe","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.coph.2016.06.008_bib0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2016.06.008_sbref0385","article-title":"Interferon-alpha acutely impairs whole-brain functional connectivity network architecture\u2014 a preliminary study","author":"Dipasquale","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0390","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/npp.2014.25","article-title":"IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy","volume":"39","author":"Haroon","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.06.008_bib0395","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopsych.2005.03.033","article-title":"Anterior cingulate activation and error processing during interferon-alpha treatment","volume":"58","author":"Capuron","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0400","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0405","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","article-title":"Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation","volume":"29","author":"D\u2019Mello","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2016.06.008_bib0410","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0415","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fncel.2015.00040","article-title":"Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis","volume":"9","author":"Cattaneo","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.coph.2016.06.008_bib0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2016.06.008_bib0425","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.coph.2016.06.008_bib0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.coph.2016.06.008_bib0435","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.coph.2016.06.008_bib0440","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.06.008_bib0445","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","article-title":"Nonclassical patrolling monocyte function in the vasculature","volume":"35","author":"Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2016.06.008_bib0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coph.2015.05.011","article-title":"PD-1\/PD-L1 inhibitors","volume":"23","author":"Sunshine","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2016.06.008_bib0455","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/NDT.S13917","article-title":"Risk factors for the development of depression in patients with hepatitis C taking interferon-alpha","volume":"7","author":"Smith","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.coph.2016.06.008_bib0460","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/npp.2015.17","article-title":"Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression","volume":"40","author":"Moieni","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.06.008_bib0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116316","article-title":"Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors","volume":"10","author":"Juhasz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2016.06.008_bib0470","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2008.08.009","article-title":"Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism","volume":"65","author":"Lotrich","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0475","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.psyneuen.2013.03.007","article-title":"Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms","volume":"38","author":"Udina","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.06.008_sbref0480","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/mp.2013.161","article-title":"Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing","volume":"19","author":"Mostafavi","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_sbref0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbi.2016.02.012","article-title":"Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress","volume":"56","author":"Kovacs","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0490","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/npp.2014.137","article-title":"Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk","volume":"39","author":"Sarginson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.06.008_bib0495","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbi.2003.11.008","article-title":"Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model","volume":"18","author":"Deinzer","year":"2004","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0500","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/cyto.1997.0290","article-title":"The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety","volume":"10","author":"Maes","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.coph.2016.06.008_bib0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","article-title":"Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor","volume":"80","author":"Iwata","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0510","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.65.4.409","article-title":"Elevated inflammation levels in depressed adults with a history of childhood maltreatment","volume":"65","author":"Danese","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0515","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","article-title":"Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy","volume":"160","author":"Capuron","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0520","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2016.06.008_bib0525","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/PSY.0000000000000004","article-title":"The buffering effect of social support on hypothalamic-pituitary-adrenal axis function during pregnancy","volume":"75","author":"Giesbrecht","year":"2013","journal-title":"Psychosom Med"},{"key":"10.1016\/j.coph.2016.06.008_bib0530","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.neuroimage.2007.01.038","article-title":"Neural pathways link social support to attenuated neuroendocrine stress responses","volume":"35","author":"Eisenberger","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.coph.2016.06.008_bib0535","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.psyneuen.2015.08.020","article-title":"Trait sensitivity to social disconnection enhances pro-inflammatory responses to a randomized controlled trial of endotoxin","volume":"62","author":"Moieni","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2016.06.008_sbref0540","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jpsychores.2015.03.005","article-title":"Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients","volume":"78","author":"Kovacs","year":"2015","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.coph.2016.06.008_sbref0545","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psym.2013.06.015","article-title":"Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis","volume":"55","author":"Sarkar","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.coph.2016.06.008_bib0550","doi-asserted-by":"crossref","DOI":"10.1080\/1028415X.2015.1123378","article-title":"Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection","author":"Chang","year":"2015","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.coph.2016.06.008_bib0555","first-page":"1","article-title":"Neuroscience, mental health and the immune system: overcoming the brain-mind-body trichotomy","author":"Pariante","year":"2015","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.coph.2016.06.008_bib0560","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pnpbp.2013.10.018","article-title":"Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants","volume":"48","author":"Leonard","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_sbref0565","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2015.11.021","article-title":"Immunomodulatory effects of fluoxetine: a new potential pharmacological action for a classic antidepressant drug?","volume":"109","author":"Di Rosso","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coph.2016.06.008_bib0570","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2016.06.008_bib0575","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13063-015-0933-5","article-title":"Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial","volume":"16","author":"Husain","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.coph.2016.06.008_bib0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:53:37Z","timestamp":1536555217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216300571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":58,"alternative-id":["S1471489216300571"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.06.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychological side effects of immune therapies: symptoms and pathomechanism","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}